MSB 16.7% $1.09 mesoblast limited

Cost of Covid Treatment in the US

  1. 97 Posts.
    lightbulb Created with Sketch. 35
    Being unfamiliar with the Australian healthcare system, I presumptively assume many Aussies may be unfamiliar with the cost of treatment in the US. These costs are largely borne by private insurers and/or the government programs; Medicare or Medicaid or the health care providers may take it on the chin for providing emergency care.

    As a Mesoblast long I had concern that the projected cost of treatment with Rem-L might limit its use.

    This brings me to the point of my post. A Seattle newspaper published the charges levied for the care of a man hospitalized for over 60 days. The charge was over $1.2 million US. A single day in the ICU was over $9,500, the charge for a ventilator was over $2,800/day and we haven't even considered the cost of doctors. drugs etc.

    Now cognizent of the savings that US payers will realize from abbreviated ICU/vent stays due to use of Rem-L, (not to mention the saving of life), alleviated my concern that price will be a limiting factor for Rem-L.

    I might add that dRump's bungling response to Covid-19 is another factor worthy of consideration in evaluating the wisdom of a Mesoblast investment.

    Fingers crossed.

    Cheers,
    MacKinnon313
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
0.155(16.7%)
Mkt cap ! $1.238B
Open High Low Value Volume
95.0¢ $1.09 94.0¢ $23.10M 22.37M

Buyers (Bids)

No. Vol. Price($)
3 13926 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 116987 8
View Market Depth
Last trade - 16.10pm 29/04/2024 (20 minute delay) ?
Last
$1.09
  Change
0.155 ( 17.4 %)
Open High Low Volume
94.0¢ $1.09 94.0¢ 3319494
Last updated 15.59pm 29/04/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.